Skip to main content
TIANYU BIO-TECHNOLOGY CO.,LTD. logo

TIANYU BIO-TECHNOLOGY CO.,LTD. — Investor Relations & Filings

Ticker · 603717 ISIN · CNE1000030W1 Shanghai Stock Exchange Manufacturing
Filings indexed 1,622 across all filing types
Latest filing 2022-08-17 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 603717

About TIANYU BIO-TECHNOLOGY CO.,LTD.

https://www.tianyubiotech.com/

TIANYU BIO-TECHNOLOGY CO.,LTD. specializes in the research, development, and large-scale production of active pharmaceutical ingredients (APIs) and advanced pharmaceutical intermediates. The company focuses on therapeutic areas such as cardiovascular health, diabetes management, and anti-viral treatments. Its core product portfolio includes various sartan-based intermediates and other complex organic synthesis products. TIANYU BIO-TECHNOLOGY emphasizes rigorous quality management systems and adheres to international regulatory standards to ensure product safety and efficacy. By leveraging advanced chemical synthesis technologies and a robust R&D infrastructure, the company provides customized manufacturing solutions and high-quality chemical components to global pharmaceutical partners. Its operations are characterized by a commitment to technical innovation and process optimization in the synthesis of complex molecules.

Recent filings

Filing Released Lang Actions
关于本次非公开发行股票不存在直接或通过利益相关方向参与认购的投资者提供财务资助或补偿的公告
Capital/Financing Update Classification · 95% confidence The document is a short announcement (460 characters) from a company regarding a non-public stock issuance, specifically stating that there is no financial assistance or compensation provided to investors participating in the subscription. It references a board meeting approving the non-public issuance plan but does not contain financial statements or detailed financial data. The content is about capital raising activities and compliance disclosures related to financing but is not a full financial report or detailed capital update. Given the short length and nature of the announcement, it fits best under Capital/Financing Update (CAP).
2022-08-17 Chinese
天域生态 非公开发行股票预案
Capital/Financing Update Classification · 95% confidence The document is titled as a "非公开发行股票预案" which translates to "Non-public Issuance of Shares Proposal." It details the company's plan for a non-public stock issuance, including background, purpose, issuance details, pricing, number of shares, use of proceeds, and regulatory approvals required. It includes extensive information about the issuance plan, the issuing company, the investor, and the regulatory framework. This is a detailed proposal document related to capital raising through a non-public share issuance. It is not an announcement of results, not a financial report, not a management or board change announcement, nor a legal or governance report. It fits the category of Capital/Financing Update (CAP) as it provides a comprehensive update on the company's financing activity through a non-public stock issuance plan.
2022-08-17 Chinese
最近五年未被证券监管部门和交易所采取监管措施或处罚的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (617 characters) from a company regarding its regulatory compliance status over the past five years, specifically stating that it has not been subject to penalties or regulatory measures by securities regulators or the stock exchange. It mentions the company's intention to apply for a non-public stock issuance but does not contain any financial data, detailed report, or presentation. The document is a regulatory compliance statement related to a financing activity but does not provide financing details itself. It is not a full report, audit, or financial statement. Given the short length and nature of the content, it fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-08-17 Chinese
关于非公开发行股票摊薄即期回报及采取填补措施和相关主体承诺的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement by Tianyu Ecological Environment Co., Ltd. regarding a non-public issuance of shares and its impact on immediate earnings dilution and the measures taken to compensate for this dilution. It includes financial assumptions, impact analysis on earnings per share and net asset returns, risk warnings, governance and fund usage measures, and commitments from the board and controlling shareholders. The content focuses on the capital raising event (non-public issuance of shares), its financial impact, and related governance and compliance measures. This fits the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes. The document is not a full financial report, earnings release, or regulatory filing but a comprehensive announcement about a financing event and its implications.
2022-08-17 Chinese
关于公司2022年半年度募集资金存放与实际使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is a detailed report on the use and management of funds raised through a non-public stock issuance in 2022, including amounts raised, usage, balances, and compliance with regulatory requirements. It references specific approvals from the China Securities Regulatory Commission and includes detailed tables on fund usage and management. The document is titled as a "专项报告" (special report) on the storage and use of raised funds for the half-year period of 2022. This type of document is a specialized report on capital raising and fund usage, which fits the category of Capital/Financing Update (CAP). It is not an annual or interim financial report, nor an announcement of voting results or management changes. The length and detail confirm it is a substantive report, not just an announcement or certification. Therefore, the correct classification is CAP with high confidence.
2022-08-11 Chinese
2022年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled '2022 年半年度报告' which translates to '2022 Semi-Annual Report'. It contains detailed financial data, management discussion and analysis, company information, financial indicators, and operational details for the period January 1, 2022 to June 30, 2022. The length is substantial (15,000 characters), and it includes actual financial statements and substantive financial data. The content matches the characteristics of an Interim / Quarterly Report, which is a comprehensive financial report for a period shorter than a full fiscal year. There is no indication that this is merely an announcement or a certification. Therefore, the document should be classified as an Interim / Quarterly Report (IR). H1 2022
2022-08-11 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.